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Objective. To examine the association between meeting behavioural goals and diabetes incidence over
10 years in a large, representative Swedish population.
Methods.Population-basedprospective cohort study of 32,120 individuals aged35 to 55 years participating in
a health promotion intervention in Västerbotten County, Sweden (1990 to 2013). Participants underwent an oral
glucose tolerance test, clinical measures, and completed diet and activity questionnaires. Poisson regression
quantiﬁed the association between achieving six behavioural goals at baseline – body mass index (BMI)
b25 kg/m2, moderate physical activity, non-smoker, fat intake b30% of energy, ﬁbre intake ≥15 g/4184 kJ
and alcohol intake ≤20 g/day – and diabetes incidence over 10 years.Results.Median interquartile range (IQR) follow-up time was 9.9 (0.3) years; 2211 individuals (7%) devel-
oped diabetes. Only 4.4% of participants met all 6 goals (n = 1245) and compared to these individuals, partic-
ipants meeting 0/1 goals had a 3.74 times higher diabetes incidence (95% conﬁdence interval (CI) = 2.50 to
5.59), adjusting for sex, age, calendar period, education, family history of diabetes, history of myocardial infarc-
tion and long-term illness. If everyone achieved at least four behavioural goals, 14.1% (95% CI: 11.7 to 16.5%) of
incident diabetes cases might be avoided.
Conclusion. Interventions promoting the achievement of behavioural goals in the general population could
signiﬁcantly reduce diabetes incidence.© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Introduction
Trials of intensive lifestyle behaviour interventions targeting indi-
viduals with impaired glucose tolerance (IGT) typically promote physi-
cal activity and healthy eating and have led to sustained reductions in
type 2 diabetes (Gillies et al., 2007; Knowler et al., 2009; Li et al.,
2008; Lindstrom et al., 2006). As a large number of people exposed to
low risk will experience more adverse events than a small number of
people exposed to high risk (Rose, 1985), we expect the majority of
incident diabetes cases to arise from the large proportion of then Sweden; EPIC-PAQ, European
cal Activity Questionnaire; FFQ,
tervention Programme.
ealth and Clinical Medicine,
en.
. Norberg).
. This is an open access article underpopulation at low risk, rather than the small proportion at high risk de-
ﬁned by IGT. Population-wide interventions are therefore predicted to
exert larger, more cost-effective and sustainable effects on population
health than interventions targeting high risk individuals (Rose, 1985).
Whether adherence to similar behavioural goals in the general popula-
tion – i.e. in larger groups of people at lower absolute risk –would reduce
diabetes incidence and exert more sustainable effects on population
health, than interventions targeting high-risk individuals, is unclear.
Evidence to directly support population-wide lifestyle interventions
as cost-effective methods of curbing the rising tide of diabetes come
mainly from modelling studies (Jacobs-van der Bruggen et al., 2007;
Vijgen et al., 2006). Prospective observational studies have shown
independent associations between adhering to individual healthy
behaviours and reduced risk of developing diabetes (Cooper et al.,
2012; de Munter et al., 2007; Hu et al., 2003; Hu et al., 2001; Koppes
et al., 2005; The InterAct Consortium, 2012a; Willi et al., 2007). In one
large population-based UK cohort, meeting ﬁve behavioural goals wasthe CC BY license (http://creativecommons.org/licenses/by/4.0/).
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(Simmons et al., 2006). In the face of a growing burden of disease asso-
ciated with rising glycaemia levels (Long et al., 2014), an improved un-
derstanding of the population impact meeting health behaviour goals
might have on diabetes risk could help optimise and reﬁne population-
level health interventions.
Data from the Swedish Västerbotten Intervention Programme (VIP)
(Norberg et al., 2010;Weinehall et al., 2001) provide a unique opportu-
nity to examine whether adherence to behavioural goals might reduce
long-term type 2 diabetes incidence in a pragmatic population-based
setting. VIP combines population-based health promotion strategies
with invitations for middle-aged inhabitants to attend systematic
cardiovascular risk factor screening in primary care. We used data
from VIP to (i) quantify the number of people meeting each of six
behavioural goals focussing on diet, physical activity (PA), smoking
and alcohol in the population, (ii) assess the association between the
achievement of baseline behavioural goals and incident diabetes over
ten years and (iii) estimate how many cases of diabetes might be
avoided if everyone achieved a range of behavioural goals.
Methods
Data source
VIP is primarily a population based intervention programme aimed at
reducing premature CVD. VIP invites all Västerbotten County inhabitants to an
individual counselling session at their primary health care centre when they
turn 40, 50 and 60 years of age and participation rate for follow-up after
10 years is around 75% (Norberg et al., 2011). VIP counselling is based on mea-
sured CVD risk factors (blood pressure, lipids, Oral Glucose Tolerance Test
(OGTT), BMI and waist circumference), and questionnaire data assessing life-
style behaviours, and the focus is to promote healthy behaviour. If measure-
ments indicate hypertension, diabetes or hyperlipidemia, individuals are
referred to usual care. CVD risk factor and questionnaire data from VIP assess-
ments, including socio-demographic characteristics and health behaviour
data, are registered in the VIP database and comprise the exposure data used
in this study. DiabNorth links the VIP database to Västerbotten County medical
records and the Swedish PrescribedDrug Register to identify all VIP participants
who have been clinically diagnosed with diabetes (Rolandsson et al., 2012).
The eligible studypopulation (n=33,142) comprises individuals aged40or
50 years at baseline VIP assessment (Norberg et al., 2010;Weinehall et al., 2001)
between 1990 and 2012, who attended at least one additional VIP follow-up as-
sessment and/or are included in the Diabetes Register in Northern Sweden
(DiabNorth). Based on the date of participation in VIP and date of diabetes diag-
nosis, prevalent cases at the time point for VIP assessment and incident cases of
diabetes thereafter can be distinguished. Individuals with prevalent diabetes atFig. 1. Incidence of type 2 diabetes over 10-years by age and baseline health behaviour
goals. Data are from Västerbotten Intervention Programme participants and presented in-
cidence rates (95% CI) are crude. Tables 2 and 3presentmodelled incidence rates byhealth
behaviour goals, adjusted for measured potential confounders.baseline, deﬁned by OGTT, self-report of diabetes or prescription of diabetes
medication at the baseline assessment were excluded (n = 999). Individuals
with incident diabetes in the year following baseline VIP assessment were ex-
cluded (n= 23). Data were available for 32,120 individuals (ESM Fig. 1). Writ-
ten informed consent was obtained from VIP participants and DiabNorth;
ethical approval was granted by the Regional Ethical Review Board, Umeå Uni-
versity [ref no: Dnr 08-131 M].
Incident type 2 diabetes ascertainment
The primary outcome was incident type 2 diabetes between baseline VIP
assessment and follow-up over 10 years. Incident cases of diabetes were
captured in two ways. Firstly, at VIP assessments by (i) OGTT (from capillary
plasma): fasting plasma glucose (FPG) ≥ 7.0 mmol/L and/or 2-hour plasma
glucose (PG) ≥ 12.2 mmol/L (Alberti and Zimmet, 1998; World Health
Organization, 1999), (ii) self-report of diabetes or (iii) self-report of diabetes
medication. For OGTTs, after an overnight fast all participants not known to
have diabetes andwith fasting plasma glucose (FPG) b7.0mmol/L, were offered
an OGTT according to the World Health Organization (WHO) criteria using a
75 g anhydrous glucose load (World Health Organization, 1999). Secondly, by
clinical diagnosis in primary or secondary care and captured in the DiabNorth
database. The vast majority, 95%, of the diabetes diagnoses were conﬁrmed
according to WHO recommendations (Rolandsson et al., 2012; World Health
Organization, 1999).
VIP health assessments, measurements and questionnaires
VIP assessments include risk factor screening at participants' local health
centre (Norberg et al., 2010). Height and weight were measured by nurses
with the participant wearing light clothing. BMI was calculated as weight
(in kg) divided by the square of height (in metres). Blood pressure (BP) was
measured twice with a mercury sphygmomanometer and the mean value
used (Ng et al., 2012a). Serum total cholesterol was analysed from venous
blood samples (Ng et al., 2012b).
All VIP participants completed the ‘Västerbotten Intervention Programme
Questionnaire’ at all assessments, which captures information on socio-
demographics, tobacco and snuff use, family history of diabetes, history ofmyo-
cardial infarction and long-term illness lasting≥6months. Physical activity was
assessed by a previously validated brief questionnaire (the short EPIC-PAQ)
(The Interact Consortium, 2012b). A total physical activity index, similar to
the Cambridge physical activity index, ranked individuals into 4 groups (inac-
tive, moderately inactive, moderately active, active) based on the cross-
tabulation of occupation and exercise (Wareham et al., 2002). A binary physical
activity variable was derived, categorizing individuals as low active (inactive
and moderately active from the total activity index), or at least moderately
active (moderately active or active). A modiﬁed and validated version of the
Northern Sweden Food Group Frequency Questionnaire (FFQ) assessed diet
and alcohol intake (Johansson et al., 2002) and daily energy/nutrient intakes
were calculated as detailed (Bergstrom et al., 1991).
Statistical analysis
All analyseswere performedusing Stata (version 13.1) software. Behavioural
goals were chosen based on the beneﬁts afforded to high risk individuals meet-
ing similar goals in diabetes prevention studies (Knowler et al., 2002;
Tuomilehto et al., 2001), and the reported beneﬁts of light/moderate alcohol
consumption (Howard et al., 2004; Koppes et al., 2005) and not using tobacco
(Willi et al., 2007) on diabetes progression. Six dichotomous behaviour
variables were derived according to the achievement of baseline goals:
BMI b25 kg/m2, moderately physical activity, total fat intake b30% of total
energy, ﬁbre intake ≥15 g/4184 kJ, non-smoker/snuff user and light/moderate
daily alcohol intake of greater than 0 g and less than 20 g per day (Swedish
recommendations are not to exceed 20 g per day http://www.vr.se/English/).
For all behaviours, the unhealthy behaviourwas the reference category. A health
behaviour scorewas constructed, for which participants scored 1 point for each
of the six health behaviours they achieved,with a higher score reﬂecting healthier
lifestyles.
We used t-tests to examine whether there were any differences in baseline
characteristics between individuals with and without follow-up data at 10
years. Poisson regression models calculated crude rate and hazard ratios (HR)
with 95% CI for the association between baseline behavioural goals and incident
diabetes. Age and calendar period comprised the underlying time-scales in all
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sessment to age at ﬁrst report of diabetes, or censor date (29th of January
2013, the last recorded VIP assessment), whichever came ﬁrst. For calendar
period, person timewas calculated from date of study entry to ﬁrst report of di-
abetes, or censor date. For analyses of individual health behaviour goals, Model
1 examined whether any of the six goals were independently associated with
incident diabetes. In Model 2, stepwise forward regression identiﬁed those
baseline health behaviours that were most strongly associated with incident
diabetes and only those behaviours that improved model ﬁt, determined via
Wald tests, were included. Model 3 additionally adjusted for family history of
diabetes, history of myocardial infarction and long-term illness lasting ≥6
months. A similar analytic approach investigated the association between the
health behaviour score and diabetes risk.
The population attributable fraction (PAF) estimated the proportion of
diabetes cases that could have been prevented in the population if everyone
adhered to behavioural goals, adjusting for all measured confounders (Model
3). To test the robustness of estimates, sensitivity analyses (i) omitting alcohol
abstainers and (ii) calculating the reduction in relative risk for each 1.5 kg/m2
difference in BMI – roughly equal to a 5% reduction in weight for most people –
were carried out (Simmons et al., 2006).Results
A total of 32,120middle-aged individuals from Västerbotten County
aged 35 to 55 years at baselinewere included in these analyses. Just overTable 1
Association between participant characteristics at baseline health assessment and incidence of
Characteristic Category/units Participant numb
All
Socio-demographic
Sex Women 17,060
Men 15,060
Ageb 35 to 39.9 years 5120
40 to 44.9 10,817
45 to 49.9 6308
50 to 54.9 9875
Educationc Basic 6555
Medium 16,839
High 8481
Marital status Single 2572
Married/partner 26,790
Divorced/separated/widow 2461
Clinical
Total cholesterol mmol/L 31,769
Systolic BP mmHg 31,641
Diastolic BP mmHg 31,630
History T2DMd 31,677
History MIe 31,816
Long-term sickf 28,972
Achievement of health behaviour goals
BMI ≥25 kg/m2 15,358
b25 kg/m2 16,484
Physical activityg Low active 15,956
At least moderate 15,157
Fibre b15 g/4184 kJ 9601
≥15 g/4184 kJ 20,263
Fat b30% of total energy intake 22,407
≥30% of total energy intake 7456
Alcohol N20 g/day and abstainers 1901
N0 g and ≤20 g/day 27,963
Tobacco Current user 10,314
Never/former user 21,166
Odds ratios for continuous/categorical exposures represent the odds of developing diabetes pe
a Adjusted for age and sex.
b At time of ﬁrst VIP survey.
c Completion of years in school: low ≤9; medium 10–12 and high ≥13 years.
d Self-reported nuclear family history of type 2 diabetes at baseline.
e Self-reported history of myocardial infarction.
f Self-reported long-term sickness lasting 6 months or more.
g Validated index based on cross-tabulation of occupational and leisure time activity (The Inhalf of the participants were women (53.1%) and belonged to an inter-
mediate social class (52.8%). Just under half the cohort were overweight
or obese (48.2%). Table 1 showsbaseline characteristics by type2diabetes
status. Over amedian (IQR) follow-up period of 9.9 (0.3) years, 2211 in-
dividuals (7%) developed type 2 diabetes (6.84 per 1000 person years at
risk; 95% CI = 6.56 to 7.13).
Having a BMI of b25 kg/m2, being at least moderately active and not
using tobacco (never or former smoker/snuff user), were independently
and inversely associated with the incidence of type 2 diabetes over 10
years, adjusting for age, sex, calendar period and education status at
baseline (Table 2. RR = 0.35, 95% CI = 0.31 to 0.38; RR = 0.84, 95%
CI = 0.77 to 0.92 and RR = 0.86, 95% CI = 0.79 to 0.94, respectively).
Mutually adjusting for all three health behaviours did not qualitatively
change the inverse associations between those behaviours and diabetes
risk (Models 2 and 3, Table 2).
Themore health behaviour goalsmet at baseline, the lower the rate of
developing type 2 diabetes over the following 10 years (Fig. 1, Table 3; p-
value for trend≤0.001). Only 100 people did notmeet any health behav-
iour goal at baseline, so individuals with a health behaviour score of 0 or
1 were combined. Compared to individuals who met 6 health behaviour
goals at baseline VIP health assessment (n=1245, 4.4%), those achieving
0/1 behaviour goals (n = 1097, 3.9%) had a 3.74 times higher rate (95%
CI = 2.50 to 5.59) of developing type 2 diabetes, adjusted for all mea-
sured confounders (Model 2, Table 3).type 2 diabetes— the Västerbotten Intervention Programme, 1990 to 2013, n = 32,120.
ers Crude odds ratioa (95% CI) Ptrend
Incident diabetes (%)
982 (5.8) 1 0.0001
1229 (8.2) 1.46 (1.33 to 1.60)
265 (5.2) 1 0.0001
550 (5.1) 0.99 (0.85 to 1.14)
559 (8.9) 1.79 (1.54 to 2.10)
837 (8.5) 1.70 (1.47 to 1.96)
593 (9.0) 1 0.0001
1184 (7.0) 0.85 (0.77 to 0.95)
401 (4.7) 0.58 (0.50 to 0.66)
240 (9.3) 1 0.0001
1729 (6.4) 0.65 (0.59 to 0.78)
216 (8.8) 0.95 (0.78 to 1.16)
2177 (6.8) 1.12 (1.07 to 1.16) 0.0001
2175 (6.9) 1.04 (1.03 to 1.04) 0.0001
2172 (6.9) 1.06 (1.05 to 1.06) 0.0001
2178 (6.9) 1.99 (1.82 to 2.17) 0.0001
2181 (6.9) 2.72 (1.66 to 4.48) 0.0001
1903 (6.6) 1.48 (1.31 to 1.67) 0.0003
1637 (10.7) 1 0.0001
546 (3.3) 0.31 (0.28 to 0.34)
1173 (7.3) 1 0.0002
930 (6.1) 0.84 (0.77 to 0.92)
686 (7.1) 1 0.0048
1307 (6.4) 0.87 (0.79 to 0.96)
1508 (6.7) 1 0.99
485 (6.5) 1.00 (0.90 to 1.12)
148 (7.8) 1 0.06
1845 (6.6) 0.84 (0.71 to 1.01)
817 (7.9) 1 0.0001
1359 (6.4) 0.82 (0.75 to 0.90)
r 1 unit/categorical increase in the exposure.
teract Consortium, 2012b).
Table 2
Numbers achieving individual health behaviour goals at baseline health survey and association of each goal with incidence of type 2 diabetes among middle-aged inhabitants of
Västerbotten County Sweden, 1990 to 2013 (n = 32,120).
Characteristic Health score n D Y Rate (95% CI) Model 1 Model 2 Model 3
Rate ratio (95% CI) Rate ratio (95% CI) Rate ratio (95% CI)
BMI
Overweight/obese 0 15,358 1637 154 10.66 (10.15 to 11.18) 1 1 1
Not overweight/obese 1 16,484 546 167 3.27 (3.01 to 3.56) 0.35 (0.31 to 0.38)c 0.34 (0.31 to 0.38)c 0.36 (0.32 to 0.40)c
Physical activity
Low active 0 15,956 1173 161 7.31 (6.90 to 7.73) 1 1 1
At least moderate 1 15,157 930 153 6.10 (5.72 to 6.50) 0.84 (0.77 to 0.92)c 0.89 (0.82 to 0.97)a 0.89 (0.81 to 0.98)a
Fibre
b15 g/4184 kJ 0 9601 686 97 7.10 (6.59 to 7.65) 1 – –
≥15 g/4184 kJ 1 20,263 1307 203 6.44 (6.10 to 6.79) 0.95 (0.86 to 1.04) – –
Fat
≥30% total energy 0 22,408 1508 225 6.70 (6.37 to 7.05) 1 – –
b30% total energy 1 7456 485 75 6.49 (5.94 to 7.10) 0.98 (0.88 to 1.09) – –
Alcohol
N20 g/day and abstainers 0 2350 148 19 7.79 (6.63 to 9.15) 1 – –
N0 g and ≤20 g/day 1 27,514 1845 280 6.57 (6.28 to 6.90) 0.90 (0.76 to 1.07) – –
Tobacco
Current user 0 10,314 817 104 7.89 (7.37 to 8.45) 1 1 1
Never/former user 1 21,166 1359 213 6.37 (6.04 to 6.72) 0.86 (0.79 to 0.94)c 0.85 (0.77 to 0.93)b 0.84 (0.76 to 0.93)c
Rates represent the incidence of developing diabetes per 1000 person years at risk and rate ratios for each behaviour represents the risk of developing diabetes per categorical increase in
the health score.
Model 1: Adjusted for sex, age, calendar period and education.Model 2: As forModel 1, andmutually adjusted for achieving BMI, tobacco and physical activity goals. Model 3: As forModel
2 and additionally adjusted for family history of diabetes, history of myocardial infarction and self-reported long-term illness lasting at least 6 months.
D, type 2 diabetes event; Y, person-years at risk (per 1000).
a p ≤ 0.05.
b p ≤ 0.001.
c p ≤ 0.0001.
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and diabetes is causal, the proportion of diabetes cases that might be
prevented in the population (PAF) rose as the number of behavioural
goals met by individuals increased (Table 4). If all participants met at
least 2 health behaviour goals at baseline, 1.5% of diabetes cases might
have been prevented and this rose to 34.4% if everyone met all 6 goals
(Table 4. 95% CI = 1.1 to 2.0% and 27.9 to 42.4%, respectively). Among
the sub-group of individuals achieving 0/1 healthy behaviours at base-
line, the attributable fractions associated with a healthy lifestyle was
even more pronounced (Table 4). Those meeting more behavioural
goals at baselineweremore likely to be female, belong to a higher socio-
economic category, be married and without a family history of diabetes
compared to those who had met fewer health behaviours (χ2 test for
trend, all p b 0.001; data not shown).
Sensitivity analyses omitting abstainers (n= 1761) did not qualita-
tively change the results (Model 1: RR, 95% CI = 0.99, 0.67 to 1.47). In
terms of differences in baseline weight, the incidence of diabetes
increased by 14% for every 1.5 kg/m2 higher BMI, adjusting for all
measured confounders (RR = 1.14, 95% CI = 1.13 to 1.15).Table 3
Health behaviour score and incidence of type 2 diabetes over a 10 year follow-up period amon
Heath score n D Y Ra
6 1245 37 (3.0) 12.5 2
5 5069 211 (4.2) 51.0 4
4 8454 460 (5.4) 84.9 5
3 8169 612 (7.5) 81.8 7
2 4452 420 (9.4) 44.5 9
0 or 1 1097 139 (12.7) 11.0 12
Ptrend
Rates represent the incidence of developing diabetes per 1000 person years at risk and rate ratio
Model 1: Adjusted for sex, age, calendar period and education. Model 2: As for Model 1, and
self-reported long-term illness lasting at least 6 months.
D, type 2 diabetes event (%); Y, person-years at risk (per 1000).Discussion
In this representative population-based cohort of 32,120 middle-
aged individuals, over half met at least 4 out of 6 behavioural goals
encompassing diet, physical activity, alcohol and tobacco use. Diabetes
incidence over 10 years of follow-up was inversely associated with the
number of behavioural goals achieved at baseline. Individuals with a
BMI of b25 kg/m2, who reported being at least moderately physically
active and who did not use tobacco had a signiﬁcantly lower risk of
developing type 2 diabetes over a decade of follow-up, compared to
individuals whowere obese/overweight, were not active or used tobac-
co. These associations were independent of measured confounders
including age, socioeconomic status, long term illness, family history
of diabetes and a history of myocardial infarction. The PAFs we report
allow us to predict what would happen to the burden of diabetes in
Sweden if we were to implement interventions that lead to
population-wide increases in the adoption and adherence to health be-
haviours. This includes the scenarios in which the population adhered
to all six health behaviours, down to at least two health behaviours.g middle-aged inhabitants of Västerbotten County Sweden, 1990 to 2013 (n = 28,343).
te (95% CI) Model 1 Model 2
Rate ratio (95% CI) Rate ratio (95% CI)
.95 (2.14 to 4.07) 1 1
.13 (3.61 to 4.73) 1.31 (0.93 to 1.86) 1.45 (0.98 to 2.13)
.42 (4.95 to 5.94) 1.73 (1.24 to 2.42) 1.97 (1.36 to 2.86)
.49 (6.92 to 8.10) 2.24 (1.60 to 3.12) 2.49 (1.72 to 3.61)
.43 (8.57 to 10.38) 2.68 (1.91 to 3.76) 2.97 (2.04 to 4.32)
.68 (10.74 to 14.98) 3.52 (2.44 to 5.07) 3.74 (2.50 to 5.59)
b0.0001 b0.0001
s represent the risk of developing diabetes per 1 unit increase in thehealth behaviour score.
additionally adjusted for family history of diabetes, history of myocardial infarction and
Table 4
The proportion of diabetes cases thatmight be prevented if all individuals achieved at least
the number of preventive health behaviour goals indicated at baseline, the Västerbotten
Intervention Programme, 1990 to 2013, n = 28,485.
Goals meta Population attributable fraction % (95% CI)
Whole populationb Population achieving 0/1 goalsc
2 goals 1.5 (1.1 to 2.0) 39.2 (26.9 to 49.5)
3 goals 5.9 (4.6 to 7.1) 26.2 (20.1 to 31.8)
4 goals 14.1 (11.7 to 16.5) 51.4 (43.4 to 58.4)
5 goals 25.8 (21.7 to 29.6) 58.2 (50.3 to 64.9)
6 goals 34.4 (27.9 to 42.4) 65.6 (57.6 to 72.1)
Adjusted for sex, age, calendar period, education, self-reported family history of diabetes,
history ofmyocardial infarction and long-term illness lasting 6months ormore. Assuming
causality between meeting health behaviour goals and diabetes, PAFs show the percent-
age of diabetes cases that might be prevented if all participants achieved at least the
number of health behaviours indicated at baseline.
a The number of preventive health behaviour goals achieved at baseline by self-report.
b The proportion of diabetes cases that might be prevented in the Västerbotten County
if all participants achieved at least the number of preventive health behaviour goals
indicated.
c The proportion of diabetes cases in unhealthy individuals (achieving 0 or 1 goals at
baseline) that might be prevented if all unhealthy participants achieved the number of
preventive goals indicated.
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be avoided in the population if everyone achieved at least 4 health be-
haviour goals. Interventions that promote the achievement of behav-
ioural goals in the general population could signiﬁcantly reduce the
burden of diabetes incidence.
Whether health behaviour interventions decrease diabetes inci-
dence on a population level, i.e. in large groups of people at lower abso-
lute risk, is not clear. Carefully conducted observational analyses
examining whether adherence to key behaviours reduce diabetes risk
in well-characterised cohorts can help elucidate whether behavioural
interventions can decrease population-wide diabetes incidence and ad-
vance our understanding of the population impact of living a healthy
life. One previous empirical study suggested that individuals who met
more of a set of ﬁve diabetes prevention goals, similar to those outlined
here were less likely to develop diabetes, with the two goals most
strongly inversely associated with diabetes incidence comprising a
BMI of less than 25 kg/m2 and being moderately active (Simmons
et al., 2006). Consistency in those behaviours most strongly inversely
associated with reduced diabetes risk over different geographic loca-
tions and time periods suggests that having a healthy body composition
and being physically activemay represent key goals to target in popula-
tion preventive strategies. An inverse association between never/for-
mer tobacco use and diabetes incidence was found, adding further
support for the health beneﬁts of not using tobacco (Rimm et al.,
1995). In addition to reduced diabetes risk, meeting similar health
behaviour goals is associated with a range of health beneﬁts, includ-
ing reductions in cardiovascular disease, premature death (Khaw
et al., 2008), cancer (Vergnaud et al., 2013) and cognitive decline
(Anton et al., 2013).
Our results suggest that the biggest effects on reducing diabetes risk
came from having a healthy body composition, beingmoderately phys-
ically active and not using tobacco. However, is it realistic to expect
adherence to such healthy behaviours in the general population?
Extrapolating from the original EPAQ2 validation study, we expect the
difference in measured PAEE between PA categories used here to
approximate 920 and 730 kJ/day in men and women, respectively. In
terms of BMI, the mean (95% CI) BMI of those with and without a
healthy body composition (b25 kg/m2) was 22.6 kg/m2 (22.6 to
22.6 kg/m2) and 28.3 (28.3 to 28.4 kg/m2), respectively. This equates
to a net difference (95% CI) in BMI of 5.7 kg/m2 (5.6 to 5.8 kg/m2)
between those who had a healthy body composition and those who
did not, which was associated with a 58% reduction in diabetes risk
over 10 years. Increases in weight during middle-age are well docu-
mented and given the difﬁculty in reducing/maintainingweight in trials(Turk et al., 2009), such large effects will be difﬁcult to achieve and sus-
tain in a real-world setting. Our ﬁndings emphasise the huge potential
for small changes in health behaviour to contribute to a reduction in
population risk, but also the difﬁculty in motivating people to meet
and maintain behavioural goals.
The difﬁculties and costs of identifying people with impaired fasting
glucose (IFG)/IGT, coupled with the low uptake of intensive interven-
tions in the high risk identiﬁed (Ruge et al., 2007) mean that traditional
individual-level intensive preventive approaches which focus on
targeting the high-risk minority are likely to be insufﬁcient to combat
the growing burden of hyperglycaemia (Rose, 1985). Thus, interven-
tions targeting the wider collective determinants of elevated blood glu-
cose levels are needed to complement intensive individual approaches
in order to drive a downward shift in the population distribution of
glycaemia (Rose, 1985). Lessons can be learned from the success of to-
bacco cessation strategies, where a combination of individual- (West
et al., 2013; West et al., 2000) and collective- (Jha and Chaloupka,
2000) level interventions have likely contributed to the halving of
smoking prevalence in the UK in recent decades, from 45% in 1974 to
20% in 2011 (Ofﬁce for National Statistics, 2011). Indeed, many tobacco
cessation interventions could be adapted to address other modiﬁable
risk factors, such as BMI and diet (Adeyi et al., 2007; Mercer et al.,
2003). Combined with population-level interventions to increase activ-
ity (NHS Health Development Agency, 2005), individual-level behav-
iour change programmes (Bravata et al., 2007), may represent one
way of increasing activity on a population-wide scale. Mass expo-
sure controls, such as population health promotion programmes
(Finnish Diabetes Association, 2003; Norberg et al., 2010) or ﬁscal
strategies for unhealthy foods (Briggs et al., 2013) could change
cultural norms and may exert additional effects on population
health.
A major strength of this study is the prospective population-
based design, comprising 32,120 individuals followed for a decade.
VIP is integrated into primary care which enabled efﬁcient data col-
lection, long-term follow-up and generalisability to similar loca-
tions. The vast majority of diabetes diagnoses were conﬁrmed via
OGTT and care was taken to exclude prevalent undiagnosed diabe-
tes cases. Use of standard operating procedures alongside a regular
training programme for VIP personal ensured robust measure-
ments across primary care centres and over time. Limitations in-
clude the use of self-report to ascertain the health behaviour
exposure which may introduce some misclassiﬁcation of the true
exposure. However, since questionnaires were completed before
diabetes ascertainment such misclassiﬁcation, if introduced, is
likely to be random and dilute true associations. The high rate of
VIP goal achievement could be driven by a ‘healthy participant
effect’. However, VIP participation rates were excellent for a
population-based programme – 56% in 1995 to ≥66% since 2005
(Norberg et al., 2012) – and evidence to support a social selection
bias was not found in previous VIP studies (Norberg et al., 2012),
consistent with the non-differential distribution of health behav-
iours by VIP participation status, but we cannot conﬁrm this.Conclusions
Type 2 diabetes incidence was inversely associatedwith the number
of behavioural goals achieved in this representative middle-aged Swed-
ish population. The healthy behaviours identiﬁed as most strongly
associated with reduced diabetes risk included having a healthy body
composition, being at least moderately active and not using tobacco.
These data demonstrate the potential for population-based prevention
approaches targeting obesity, physical activity, tobacco use and diet to
control the rising burden of diabetes and highlights the need for
additional strategies to address the growing burden of disease associated
with unhealthy lifestyles.
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